India to Iraq: Niacin Export Trade Route

The India to Iraq Niacin corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $111.0K USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's niacin manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $111.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with niacin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 18.4%, placing it at rank #11 among India's top niacin export destinations globally.

On the import side, key buyers of Indian niacin in Iraq include AL-THURAYA SCIENTIFIC DRUG BUREAU. AL-THURAYA SCIENTIFIC DRUG BUREAU is the single largest importer with 1 shipments valued at $111.0K USD.

India's niacin exports to Iraq are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Iraq benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AJANTA PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $111.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

On the buying side, AL-THURAYA SCIENTIFIC DRUG BUREAU is the largest importer with 1 shipments worth $111.0K USD — representing 100% of all niacin imports from India on this route.